[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"gait-biomechanics\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:gait-biomechanics":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,51,83],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":15,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":32,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":39,"lastUpdatePostDateStruct":40,"startDateStruct":43,"completionDateStruct":45,"leadSponsor":47,"locationsCount":50},"100642340","the-effect-of-lateral-wedge-insoles-on-lower-limb-biomechanics-muscle-activity-and-knee-adduction-moment-during-walking-and-running-100642340",false,"NCT07639411","The Effect of Lateral Wedge Insoles on Lower Limb Biomechanics, Muscle Activity and Knee Adduction Moment During Walking and Running","Inclusion Criteria:\n\n* Being able to walk and run 10 meters without assistance\n* Not having sustained any injury to the lower extremities, pelvis, or trunk within the past 12 months\n* Not having received any treatment for the lower extremities, pelvis, or trunk within the past 6 months\n* Shoe size must be between EU 36 (22 cm) and EU 45 (28 cm) according to European Union (EU) standards\n* Must have scored between 0 and +5 on the Foot Posture Index scale for both feet\n* Have scored between 0 and 20 on the Revised Foot Function Index questionnaire\n* Have a body mass index (BMI) between 18 and 25 kg\u002Fm²\n\nExclusion Criteria:\n\n* Having cognitive impairment, vision or hearing problems, or a systemic disease that could affect overall health\n* Having deformities, contractures, or any other abnormalities in the trunk or lower extremities that could affect participation\n\n  • Having a diagnosed foot or ankle deformity (e.g., pes planus, pes cavus, hallux valgus, etc.)\n* Having any neurological or muscular disorder\n* Being an active professional athlete\n* Failure to sign the informed consent form",true,"ALL","18 Years","40 Years",{"count":20,"type":21},30,"ESTIMATED","INTERVENTIONAL",[24],"NA","The aim of this prospective, randomized, single-group interventional study is to use quantitative methods to investigate the acute effects of using lateral-wedge insoles on lower extremity biomechanics, muscle activation patterns, and knee adduction moment during walking and running activities in healthy individuals aged 18-40. The primary research questions it seeks to answer are as follows:\n\n* Do lateral wedge insoles cause a significant change in knee adduction moment?\n* Do lateral wedge insoles change lower extremity biomechanics during walking and running?\n* Do lateral wedge insoles change the activation patterns of lower extremity muscles during walking and running? To compare the effectiveness of lateral wedge insoles, participants will randomly use insoles with 0 (neutral), 5, and 10-degree angles.\n\nParticipants will do the following:\n\n* Put on the shoes and insoles provided to you in the motion analysis laboratory and complete the walking and running protocols, each taking 1 minute, on the treadmill.\n* While walking at your normal walking speed, step so that your dominant leg is positioned over the force plate.\n* Repeat all of this for the insoles at the other two angles.",[27,28,29,30,31],"Biomechanical Changes","Gait Biomechanics","Gait Analysis in Healthy Subjects","Running Kinematics","EMG",[33,34,35,36,37],"Lateral Wedges İnsoles","Knee Adduction Moment","Gait Analysis","Running Analysis","EMG Activity","NOT_YET_RECRUITING","2026-06-06",{"date":41,"type":42},"2026-06-10","ACTUAL",{"date":44,"type":21},"2026-06",{"date":46,"type":21},"2027-06",{"name":48,"class":49},"Ankara Yildirim Beyazıt University","OTHER",2,{"id":52,"slug":53,"hasResults":11,"nctId":54,"briefTitle":55,"officialTitle":56,"acronym":57,"eligibilityCriteria":58,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":59,"enrollmentInfo":60,"targetDuration":4,"studyType":22,"phases":62,"briefSummary":63,"conditions":64,"keywords":68,"overallStatus":71,"whyStopped":4,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":75,"completionDateStruct":77,"leadSponsor":79,"locationsCount":82},"100633620","the-potential-of-robotic-assisted-gait-training-in-a-rehabilitation-setting-100633620","NCT07529054","The Potential of Robotic-Assisted Gait Training in a Rehabilitation Setting","The Potential of Robotic-Assisted Gait Training in a Rehabilitation Settin","RAGT_RGB","Inclusion Criteria:\n\n* Diagnosis of stroke (ischemic or hemorrhagic) ≥ 3 months\n* Age ≥ 18a and ≤ 80a\n* 6MWT ≤ 200m\n* Barthel Index ≤ 95\n* Mini Mental State Exam (MMSE) ≥ 24\n* FAC: ≤ 4\n* BBS): ≤49\n* Modified Ashworth Scale (MAS): 0-3 for the lower extremity\n\nExclusion Criteria:\n\n* The presence of any comorbidity or disability other than stroke that would preclude gait training\n* Any uncontrolled health condition for which exercise is contraindicated","80 Years",{"count":61,"type":21},40,[24],"Robotic-assisted gait training (RAGT) devices, such as the Lokomat®, are commonly used to support gait rehabilitation by enabling repetitive, task-specific walking movements. The functional proprioceptive stimulation (FPS) device Vibramoov® represents a novel technology designed to stimulate proprioceptors at the muscle-tendon junction through targeted vibratory stimuli, thereby activating sensorimotor centers in the brain and potentially facilitating movement execution.\n\nThe aim of this randomized controlled trial is to investigate whether Lokomat® training combined with Vibramoov® leads to greater improvements in qualitative and quantitative gait parameters in stroke patients compared with Lokomat® training alone. The study will be conducted at the Gröbming Rehabilitation Center and will include patients undergoing a four-week neurological inpatient rehabilitation program. Participants will be randomly assigned to an intervention group (Lokomat® + Vibramoov®) or a control group (Lokomat® only), with 20 patients per group.\n\nPrimary outcomes include the 6-Minute Walk Test (6MWT) and spatiotemporal gait parameters. Additional assessments include functional scores, patient-reported outcome measures, and blood biomarkers. Statistical analyses will be performed depending on data distribution. A follow-up assessment evaluating EQ-5D and PHQ-4 will be conducted six months after completion of the rehabilitation program.",[65,66,67,28],"Stroke","Robotic Assisted Gait Training","Vibration Therapy",[66,69,70],"Functional Proprioceptive Stimulation","Gait Parameter","RECRUITING","2026-04-07",{"date":74,"type":42},"2026-04-14",{"date":76,"type":42},"2026-01-05",{"date":78,"type":21},"2027-12",{"name":80,"class":81},"Ludwig Boltzmann Institute for Arthritis and Rehabilitation","NETWORK",1,{"id":84,"slug":85,"hasResults":11,"nctId":86,"briefTitle":87,"officialTitle":88,"acronym":4,"eligibilityCriteria":89,"healthyVolunteers":11,"sex":16,"minAge":18,"maxAge":4,"enrollmentInfo":90,"targetDuration":4,"studyType":22,"phases":91,"briefSummary":92,"conditions":93,"keywords":98,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":102,"lastUpdatePostDateStruct":103,"startDateStruct":105,"completionDateStruct":107,"leadSponsor":109,"locationsCount":82},"100622301","the-effects-of-manual-therapy-on-the-spatiotemporal-gait-characteristics-in-patients-with-chronic-obstructive-pulmonary-disease-100622301","NCT07381842","The Effects of Manual Therapy on the Spatiotemporal Gait Characteristics in Patients With Chronic Obstructive Pulmonary Disease","An Investigation of the Effects of Manual Therapy on the Spatiotemporal Gait Characteristics in Patients With Chronic Obstructive Pulmonary Disease","Inclusion Criteria:\n\n* Age 40 years or older\n* Clinically stable for at least the past 4 weeks\n* Classified as GOLD stage 1, 2, or 3 according to the Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) airflow limitation classification\n* Classified as group A, B, or E according to the GOLD ABE assessment tool\n\nExclusion Criteria:\n\n* Use of walking assistive devices\n* Receiving long-term oxygen therapy\n* Presence of additional orthopedic, neuromuscular, neurological, or cardiac conditions that may affect gait and balance\n* History of lung cancer, sarcoidosis, tuberculosis, and\u002For lung surgery\n* Presence of musculoskeletal conditions such as fibromyalgia, rheumatoid arthritis, or osteoarthritis\n* Presence of a known mental or cognitive impairment",{"count":61,"type":21},[24],"The primary aim of this study is to investigate the effects of manual therapy on spatiotemporal characteristics of gait and gait variability, functional exercise capacity, and pulmonary function in patients with chronic obstructive pulmonary disease (COPD).\n\nThe secondary aims of the study are to determine the effects of manual therapy on balance, respiratory muscle strength, quality of life, physical activity, symptom severity, accessory respiratory muscle activation, peripheral muscle strength, chest wall mobility, dysfunctional breathing, pain, and posture.",[94,95,28,96,97],"COPD (Chronic Obstructive Pulmonary Disease)","Manuel Therapy","Muscle Energy Technique","Functional Capacity",[99,100,101],"COPD","Gait","Manuel therapy","2026-01-26",{"date":104,"type":42},"2026-02-02",{"date":106,"type":21},"2026-02-08",{"date":108,"type":21},"2028-01-08",{"name":110,"class":49},"Hacettepe University"]